Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.
Samjin Pharmaceuticals Dividend Announcement
• Samjin Pharmaceuticals announced a annually dividend of ₩800.00 per ordinary share which will be made payable on 2024-04-15. Ex dividend date: 2023-12-27
• Samjin Pharmaceuticals annual dividend for 2023 was ₩800.00
• Samjin Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 4.4%
• Samjin Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is 26.61%
• Samjin Pharmaceuticals's dividend growth over the last ten years (2013-2023) was 7.18% year
Samjin Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-27 | ₩800.00 | annually | 2024-04-15 |
2022-12-28 | ₩800.00 | annually | 2023-04-10 |
2021-12-29 | ₩800.00 | annually | 2022-04-18 |
2020-12-29 | ₩800.00 | annually | 2021-04-19 |
2019-12-27 | ₩800.00 | annually | 2020-04-13 |
2018-12-27 | ₩800.00 | annually | 2019-04-15 |
2017-12-27 | ₩800.00 | annually | 2018-04-09 |
2016-12-28 | ₩700.00 | annually | |
2015-12-29 | ₩600.00 | annually | |
2014-12-29 | ₩500.00 | annually | |
2013-12-27 | ₩400.00 | annually | |
2012-12-27 | ₩300.00 | annually |
Samjin Pharmaceuticals Dividend per year
Samjin Pharmaceuticals Dividend growth
Samjin Pharmaceuticals Dividend Yield
Samjin Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 4.4%. Interested in purchasing Samjin Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Samjin Pharmaceuticals Financial Ratios
Samjin Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Samjin Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Samjin Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Samjin Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Samjin Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Samjin Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Samjin Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Samjin Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Samjin Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Samjin Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Samjin Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Samjin Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.